Important Protein Complex That Allows Certain Cancer Drugs to be Effective is Discovered
geralt / Pixabay

Important Protein Complex That Allows Certain Cancer Drugs to be Effective is Discovered

According to a story from rdmag.com, researchers from the University of Toronto have discovered a critical mechanism that helps facilitate the normal DNA repair process. This mechanism could have implications…

Continue Reading Important Protein Complex That Allows Certain Cancer Drugs to be Effective is Discovered
Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease
nuzree / Pixabay

Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease

According to a public release from University of Texas Health Center at San Antonio on eurekalert.org, research using fruit fly tauopathy disease models has revealed a genetic "copy-paste" activity that…

Continue Reading Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease

Results From Studies of an Experimental Drug for Chronic Kidney Disease Have Been Announced

Results from two studies looking at the effects of an experimental drug (bardoxolone) on kidney function in patients with chronic kidney disease (CKD) have been released. One of the studies…

Continue Reading Results From Studies of an Experimental Drug for Chronic Kidney Disease Have Been Announced
New Guidelines Cite the Need for Better Support for Complex Regional Pain Syndrome Patients
geralt / Pixabay

New Guidelines Cite the Need for Better Support for Complex Regional Pain Syndrome Patients

According to a story from the Royal College of Physicians, the organization has chosen to release new guidelines regarding the treatment of patients with complex regional pain syndrome, a potentially…

Continue Reading New Guidelines Cite the Need for Better Support for Complex Regional Pain Syndrome Patients
October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
mohamed_hassan / Pixabay

October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease

An ongoing Phase 3 clinical trial program is investigating the drug PXT3003 as an experimental treatment for Charcot-Marie-Tooth disease type 1A in adults. Pharnext SA says that they expect to…

Continue Reading October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome
rawpixel / Pixabay

The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome

The first patient has been enrolled onto a Phase 3 clinical trial investigating topical dermal reproxalap as a possible treatment for Sjögren-Larsson syndrome associated ichthyosis. The original article can be read…

Continue Reading The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome
Researchers Investigated the Role of Technology in Self-Management of Sickle Cell Disease
kaboompics / Pixabay

Researchers Investigated the Role of Technology in Self-Management of Sickle Cell Disease

Researchers have investigated whether self-management electronic health (eHealth) interventions, such as text messaging, apps, and online cognitive-behavioural therapy, should be used to help patients with sickle cell disease self-manage the…

Continue Reading Researchers Investigated the Role of Technology in Self-Management of Sickle Cell Disease
The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis
Aymanjed / Pixabay

The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis

The US Food and Drug Administration has awarded Orphan Drug Designation to the drug lenabasum as a treatment for dermatomyositis. The use of lenabasum for treating this condition, and others,…

Continue Reading The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis

A Long Term Study of a Treatment for Autosomal Dominant Polycystic Kidney Disease Has Finished

According to a story from Medical Xpress, a long term study testing a treatment for autosomal dominant polycystic kidney disease (ADPKD) has recently concluded. The treatment in question is a…

Continue Reading A Long Term Study of a Treatment for Autosomal Dominant Polycystic Kidney Disease Has Finished
Three Planned Studies of an Experimental Drug to Treat Rare Epilepsies Have Been Announced
kkolosov / Pixabay

Three Planned Studies of an Experimental Drug to Treat Rare Epilepsies Have Been Announced

The organisations Takeda Pharmaceutical Company and Ovid Therapeutics are collaborating over the development of the experimental drug TAK-935/OV935 as a possible treatment for several rare epilepsy syndromes. Takeda has just…

Continue Reading Three Planned Studies of an Experimental Drug to Treat Rare Epilepsies Have Been Announced
Treating Fetuses With Gene Therapy Could Minimize the Damage From Genetic Disorders Like Gaucher Disease
sbtlneet / Pixabay

Treating Fetuses With Gene Therapy Could Minimize the Damage From Genetic Disorders Like Gaucher Disease

According to a story from nature.com, gene therapy administered to fetuses could help curtail some of the worst effects of deadly genetic disorders. In a mouse model study, fetal delivery…

Continue Reading Treating Fetuses With Gene Therapy Could Minimize the Damage From Genetic Disorders Like Gaucher Disease